---
category: news
title: "BioXcel Therapeutics Presents Results from Ongoing Phase 2 Trial of BXCL701 in Combination with ..."
excerpt: "BXCL701 plus KEYTRUDAÂ® (pembrolizumab) demonstrates encouraging anti-tumor activity in heavily pre-treated mCRPC patients with adenocarcinoma. BXCL701 combination continues to ex"
publishedDateTime: 2021-09-15T22:07:00Z
originalUrl: "https://apnews.com/press-release/globe-newswire/technology-business-health-coronavirus-pandemic-tumors-b2036ef8ae606cd13d47ba18d80905db"
webUrl: "https://apnews.com/press-release/globe-newswire/technology-business-health-coronavirus-pandemic-tumors-b2036ef8ae606cd13d47ba18d80905db"
type: article

provider:
  name: Associated Press
  domain: apnews.com

topics:
  - AI in Healthcare
  - AI

images:
  - url: "https://apnews.com/images/PaidContent3.png"
    width: 700
    height: 450
    isCached: true

secured: "OV1HfePx20mzgk3Rli1+elRzROn19d2j58ceaCufLXqLydQRjLtzxCFkjqDygBXnWhxTtICbHqCJ8dBjOgffPH37qIIs3tix9aPgVOCC1cAc1VX90DErmcNNGKpPJxKaopkANekhcRGsrM3hLvR9H0Wcjx/VPq/E5677m3JbiUo23cZf58VRmf0W31Gp2JejgN90H53XAzGuU2iAE4e0TxVzhJrCb8jwrxLEgrKHweBFXs6JHXPF3Zr7tQ5T2AK/LBGQaZjKVfoCUvLZ8NCEaY88n+Z8ZDfCOe10IUo0Mywhbt0PnJMO63nV3y311LcaOAIpeWoi3aHcRX6k2zqiFYNEX+tZKTgcvy2otSZby5g=;MFVM2iHlX2p9zUiwVblnKA=="
---

